Views & Analysis Digital tools driving innovative clinical trials The COVID-19 pandemic has catalysed significant changes in the way pharma develops drugs, particularly in the cl
News Thread builds in decentralised trials again with CureClick b... Just over a year after partnering on a project to accelerate recruitment into decentralised clinical trials (DCTs), Thread and CureClick have decided to formally tie the knot.
News Amazon gathers Thread in decentralised trials alliance Amazon's latest push into the healthcare arena is focusing on one of the top new trends in clinical research – the shift towards decentralised trials.
News Thread, Eversana join forces on real-world data platform Eversana's expansion into real-world data (RWD) handling has gathered pace via an alliance with Thread, a specialist in decentral
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
